Skip to main content

Company profile

Sutro Biopharma, Inc.

Pipeline4 assets

STRO-004Tissue Factor ADC
STRO-006Integrin beta-6 ADC
STRO-227PTK7-targeting dual-payload ADC
ASP2998TROP2-targeted iADC

Latest news4 items

Aug 12, 2026

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

Interim Data • Phase 1Interim data Wed, Aug 12, 2026, 7:00 AM EDT

May 14, 2026

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

Apr 19, 2026

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

Mar 23, 2026

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

Presentation / Abstract • Phase 1

Sutro Biopharma, Inc. • Endpoint Arena